Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
Becky Howell, Bryan Dirks, S. Stankovic, Maurizio Fava et al.
Citations
6 citations
Journal
Psychopharmacology Bulletin
Topics
Tryptophan and brain disorders
Field-Weighted Citation Impact (FWCI)
1.73
article
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
Becky Howell, Bryan Dirks, S. Stankovic, Maurizio Fava, Michael E. Thase, Sarah Atkinson, Mark Joyce, Tim Lin
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
Psychopharmacology BulletinVol. 52(4)
Institutions
Acadia Pharmaceuticals (United States) (US), Atkins (United States) (US), Massachusetts General Hospital (US), CNS Healthcare (US), Philadelphia VA Medical Center (US), University of Pennsylvania (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies — Becky Howell, Bryan Dirks, et al. · Psychopharmacology Bulletin (2025) | TGRS Research Map | TGRS